SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-031683
Filing Date
2021-09-17
Accepted
2021-09-17 16:43:10
Documents
14
Period of Report
2021-09-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10028962_8k.htm   iXBRL 8-K 34505
2 EXHIBIT 5.1 brhc10028962_ex5-1.htm EX-5.1 8044
6 image00001.jpg GRAPHIC 3027
  Complete submission text file 0001140361-21-031683.txt   186304

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210917.xsd EX-101.SCH 3917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210917_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210917_pre.xml EX-101.PRE 16038
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10028962_8k_htm.xml XML 4227
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 211260973
SIC: 2833 Medicinal Chemicals & Botanical Products